The limited clinical utility of a routine creatine kinase (CK) on admission to a psychiatric inpatient unit
The clinical utility of untargeted screening using a serum CK for psychiatric inpatients appears limited, with poor specificity in detection of NMS and a minimal impact on subsequent clinical management.
Authors
- Fraser Scott (ORCID: https://orcid.org/0000-0001-5750-1752)
- Matthew Butler (ORCID: https://orcid.org/0000-0002-9734-6539)
- Jonathan Rogers (ORCID: https://orcid.org/0000-0002-4671-5410)
Institutions
- St Thomas' Hospital (GB)
- King's College London (GB)
- South London and Maudsley NHS Foundation Trust (GB)
- University College London (GB)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12888-024-06386-8
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- National Institute for Health and Care Research
- Department of Health and Social Care
- King's College London
- NIHR Maudsley Biomedical Research Centre